186 related articles for article (PubMed ID: 25128299)
1. Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B.
Liu YR; Lin BB; Zeng DW; Zhu YY; Chen J; Zheng Q; Dong J; Jiang JJ
BMC Gastroenterol; 2014 Aug; 14():145. PubMed ID: 25128299
[TBL] [Abstract][Full Text] [Related]
2. Serum Alpha-Fetoprotein as a Predictor of Liver Fibrosis in HBeAg-Positive Chronic Hepatitis B Patients.
Yang K; Pan Y; Liu L; Sun B; Shi W
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241155
[No Abstract] [Full Text] [Related]
3. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
[TBL] [Abstract][Full Text] [Related]
4. Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease.
Zeng DW; Liu YR; Zhang JM; Zhu YY; Lin S; You J; Li YB; Chen J; Zheng Q; Jiang JJ; Dong J
PLoS One; 2013; 8(10):e77942. PubMed ID: 24282481
[TBL] [Abstract][Full Text] [Related]
5. A noninvasive diagnostic model for significant liver fibrosis in patients with chronic hepatitis B based on CHI3L1 and routine clinical indicators.
Huang Q; Wu J; Huang C; Wang X; Xu Z
Ann Palliat Med; 2021 May; 10(5):5509-5519. PubMed ID: 34107703
[TBL] [Abstract][Full Text] [Related]
6. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.
Liu XD; Wu JL; Liang J; Zhang T; Sheng QS
World J Gastroenterol; 2012 Jun; 18(22):2784-92. PubMed ID: 22719186
[TBL] [Abstract][Full Text] [Related]
7. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
Li Q; Song J; Huang Y; Li X; Zhuo Q; Li W; Chen C; Lu C; Qi X; Chen L
Medicine (Baltimore); 2016 Apr; 95(16):e3372. PubMed ID: 27100421
[TBL] [Abstract][Full Text] [Related]
8. Association of α-fetoprotein levels with liver stiffness measurement in outpatients with chronic hepatitis B.
Wang J; Zhang P; Liao J; Zhu Y; Liu X; Tang H
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289529
[TBL] [Abstract][Full Text] [Related]
9. Staging liver fibrosis in chronic hepatitis B with T
Yang L; Ding Y; Rao S; Chen C; Wu L; Sheng R; Fu C; Zeng M
J Magn Reson Imaging; 2017 Apr; 45(4):1186-1194. PubMed ID: 27563840
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection.
Ma J; Jiang Y; Gong G
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):428-34. PubMed ID: 23358121
[TBL] [Abstract][Full Text] [Related]
11. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
[TBL] [Abstract][Full Text] [Related]
12. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
[No Abstract] [Full Text] [Related]
13. Novel scores combining AFP with non-invasive markers for prediction of liver fibrosis in chronic hepatitis C patients.
Gamil M; Alboraie M; El-Sayed M; Elsharkawy A; Asem N; Elbaz T; Mohey M; Abbas B; Mehrez M; Esmat G
J Med Virol; 2018 Jun; 90(6):1080-1086. PubMed ID: 29315641
[TBL] [Abstract][Full Text] [Related]
14. Serum WFA
Zou X; Zhu MY; Yu DM; Li W; Zhang DH; Lu FJ; Gong QM; Liu F; Jiang JH; Zheng MH; Kuno A; Narimatsu H; Zhang Y; Zhang XX
Liver Int; 2017 Jan; 37(1):35-44. PubMed ID: 27300763
[TBL] [Abstract][Full Text] [Related]
15. [Relation between HBsAg levels during the immune clearance phase of hepatitis B virus infection and liver pathological stages of chronic hepatitis B].
Zeng DW; Dong J; Chen LH; Zhu YY; Chen J; Zheng Q; Liu YR; Jiang JJ
Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):746-50. PubMed ID: 23207334
[TBL] [Abstract][Full Text] [Related]
16. A novel non-invasive index using AFP and APTT is associated with liver fibrosis in patients with chronic hepatitis B infection: a retrospective cohort study.
Feng L; Sun K; Zhang J; Feng G; Zhao Y
BMJ Open; 2015 Sep; 5(9):e008032. PubMed ID: 26391629
[TBL] [Abstract][Full Text] [Related]
17. Correlations between serum hepatitis B surface antigen and hepatitis B core antibody titers and liver fibrosis in treatment-naïve CHB patients.
Li MR; Zheng HW; Ma SM; Liu YY; Qie LX; Li JQ; Wang DH; Sun XL; Ren GF; Zheng YH; Wang YL; Dai EH
J Chin Med Assoc; 2018 Dec; 81(12):1052-1059. PubMed ID: 30143430
[TBL] [Abstract][Full Text] [Related]
18. Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B.
Zeng X; Xu C; He D; Li M; Zhang H; Wu Q; Xiang D; Wang Y
Croat Med J; 2015 Jun; 56(3):272-9. PubMed ID: 26088852
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
Liu DP; Lu W; Zhang ZQ; Wang YB; Ding RR; Zhou XL; Huang D; Li XF
J Viral Hepat; 2018 May; 25(5):581-589. PubMed ID: 29230907
[TBL] [Abstract][Full Text] [Related]
20. [Study on heme oxygenase-1 and HAP model for the diagnosis of chronic hepatitis B-related liver fibrosis].
Xue NN; Yuan XW; Zhao W; Tang YH; Zhang XX; Wang YQ; Zhao DD; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2021 Aug; 29(8):743-747. PubMed ID: 34517454
[No Abstract] [Full Text] [Related]
[Next] [New Search]
